All Posts
Beta Thalassemia Treatment – Insights Into the Challenges & Solutions
Beta Thalassemia (β-Thalassemia) is a blood disorder characterized by reduced synthesis of the hemoglobin subunit beta (hemoglobin beta chain) that results in microcytic hypochromic anemia, an abn...
Suneva Medical-Viveon Health merger update; Smith+Nephew acquires Engage Surgical; Abiomed’...
Suneva Medical Inc. inked a merger agreement with Viveon Health On January 12, 2022, Suneva Medical Inc., a leading regenerative aesthetics company, and Viveon Health Acquisition Corp., a parti...
Robotic Surgery: Navigating the Growing Demand, Ongoing Trends & Developments in the Global ...
It's no longer startling to learn that the best-performing surgeon at a hospital isn't human. With their unrivaled precision and ability to work without fatigue, medical robots are one of the most...
Algernon’s NP-120 (ifenprodil); Pieris’s cinrebafusp alfa (PRS-343) clinical trial; Gaumard...
Algernon receives positive FDA feedback on Phase IIb chronic cough trial The US Food and Drug Administration (FDA) has given positive feedback for Algernon Pharmaceuticals’ Phase IIb clinical t...
Neuroprosthetics Market to Reach USD 11.32 Billion, What Are the Driving Factors Behind It?
As the name suggests, Neuroprosthetics is a combination of neural processing with prosthetics. The Neuroprosthetics devices interface with the human brain to control artificial limbs. These are di...
Most Promising Oncological Drugs Expected to Launch in 2022
The innovation in the oncology drug pipeline has resulted in a record number of FDA and EU approvals in recent years, as investigators and sponsors seek new and targeted treatments for individuals...
Leman Micro Devices’ e-Checkup system; Calon Cardio-Technology & Leviticus-Cardio announced ...
Leman Micro Devices tested against the cuffed blood measurement devices reported positive results On January 07, 2022, the e-Checkup system by Leman Micro Devices tested in the world’s first c...
Insights into the Evolving Landscape of Antibody-Drug Conjugate (ADC) & the Key Companies in...
In the year 2000, the first-ever Antibody-drug Conjugate (ADC) - Mylotarg, was launched by Pfizer and was considered a miracle in cancer treatment. And it appeared like there was no looking back f...
Noxxon’s NOX-A12 clinical trial; Exact Sciences buys PreventionGenetics; Nuvalent’s clinical trai...
Noxxon continues enrolment in a glioblastoma therapy trial Noxxon Pharma continues subject enrolment in the GLORIA clinical trial of NOX-A12 in brain cancer (glioblastoma) patients. The move co...
Novel and Emerging Metastatic Colorectal Cancer Treatment Drugs Anticipated to Change Market Dyna...
Colorectal cancer is a disease in which malignant (cancer) cells form in the tissues of the colon or the rectum. Colorectal Cancer is the third most lethal and fourth most commonly diagnosed cance...
Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond
With the advent of new-age healthcare industry trends that are evident as of now, there...
Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021
Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...
Analyzing the Key Trends Driving the Biosimilar Market Growth
The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...
CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...
Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...
Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...
There has been limited progress in the approval of novel agents in MDS. It has been a l...
Sign up For Newsletters
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
